Drawing for BIOGIOX

USPTO serial 79381168

BIOGIOX

Reviewed by CopyMark Law Group

Reg. 7636786Status 700Registered
Filing date
Status date
Registration date
Jan 7, 2025
Examiner
LATTUCA, FRANK J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BIOGIOX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith Birch Stewart Kolasch & Birch LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical or veterinary purposes; antiviral pharmaceutical preparations; disinfectants for hygiene purposes; chemical reagents for medical or veterinary purposes; cultures of microorganisms for medical or veterinary use; Chinese patent medicines, namely, Angelica; bacterial preparations for medical purposes; reagents for medical purposes; diagnostic strips for testing breast milk for medical purposes; dietetic foods adapted for medical purposes; depuratives for the body; pesticides; first-aid kits; medical dressings; disinfectant wipes; dental lacquer; diapers for petsACTIVE—
010Medical diagnostic apparatus and instruments used for analyzing and diagnosing the causes of diseases based on medical purposes, namely, diagnostic equipment for detecting pathogens, immunochemistry medical diagnostic testing equipment for detecting and measuring antibody levels, mainly involving respiratory infections, eye infections, sexually transmitted diseases, bacterial skin infections, central nervous system infections, blood borne diseases, and gastrointestinal infections; incubators for medical purposes; apparatus for taking blood samples; diagnostic apparatus for the detection of abnormal prion protein; cases fitted for medical instruments; analysers for bacterial identification for medical purposes; surgical robots; apparatus for DNA and RNA testing for medical purposes; infrared thermometers for medical purposes; nucleic acid testing apparatus for medical purposes; electric dental apparatus, namely, electric dental flusher; electronic temperature monitors for medical purposes; ultrasonic diagnostic apparatus for medical purposes; X-ray apparatus for medical purposes; gloves for medical purposes; sanitary dust masks for medical purposes; feeding bottles; non-chemical contraceptives, namely, condoms; surgical implants comprised of artificial materials; orthopedic articles, namely, orthotics for the upper extremities; suture materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 7, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 7, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 15, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 15, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 12, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 12, 2024RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2024DOCKASSIGNED TO EXAMINER—
Oct 24, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance